Price Move History
- Daily moves over 5%
- 38 170 sessions, October 16, 2025 to October 16, 2026
- Largest daily move
- +100% close of December 16, 2025
- 1-year change
- +0% closing prices, October 16, 2025 to October 16, 2026
- 1-month change
- +0% closing prices, September 15, 2026 to October 16, 2026
Company Description
CBD of Denver, Inc. (CBDD) is a diversified holding company that trades on the OTC Pink market. According to its public communications, the company is focused on acquiring profitable assets at attractive valuations with the goal of creating value for shareholders. Its team emphasizes sourcing high-margin, innovative products and business models that align with its stated values.
Over time, CBD of Denver has evolved from a cannabis-focused business into a broader platform. The company describes itself as a holding company that incubates and accelerates a range of businesses, with a growing emphasis on technology-driven sectors. These include areas such as digital payments, blockchain, artificial intelligence and other scalable, tech-enabled solutions, alongside activities connected to the cannabis industry through its association with Luxora Inc.
Business focus and strategy
In its recent updates, CBD of Denver states that it is repositioning itself as a dynamic holding company. The company highlights two core elements of its approach:
- Acquiring profitable assets: CBD of Denver aims to identify and acquire businesses or assets that it believes can contribute positively to its overall portfolio and support long-term value creation.
- Emphasis on high-margin, innovative products: Management repeatedly notes a focus on products and business models that can support higher margins, whether in consumer products, wholesale activities, or technology-enabled services.
The company has also communicated a focus on maintaining financial discipline, reducing operating expenses and improving its capital structure, including avoiding new convertible debt and working with what it describes as friendly debt holders.
Wholesale and cannabis-related activities
CBD of Denver reports that its wholesale CBD division has been an important contributor to revenue. Through its association with Luxora, the company has been active in the European cannabis sector, particularly in Germany. Public statements describe Luxora Inc. as a business that operates in the legalized cannabis market, offering infrastructure solutions, consulting, market research, product development and distribution solutions tailored to the needs of that sector.
The company has also reported on its participation in cannabis industry events and initiatives. For example, CBD of Denver and Luxora presented a handheld near-infrared spectroscopy solution called CheckMyWeed at a major trade fair in Berlin. According to the company, this device is used to analyze cannabinoid content, moisture and active water content in cannabis flower and resin within seconds, with results displayed via a smartphone app on a subscription basis. CBD of Denver has indicated that it is testing the viability of such higher-margin, technology-based business models in connection with cannabis legalization and Cannabis Clubs in Germany.
German market and strategic shifts
The German cannabis market has been a recurring theme in the company’s communications. CBD of Denver has described efforts to work within the framework of the Cannabis Act (CannG) and related regulations, including attempts to introduce Grow Hub infrastructure models and to support Cannabis Clubs. The company has also reported on the regulatory complexity and bureaucratic hurdles in Germany, noting that approvals for cannabis-related business models have been limited and that requirements differ by federal state.
In more recent updates, CBD of Denver has stated that it will no longer seek to provide services to the German cannabis market due to political and regulatory uncertainties. The company characterizes this as a shift in focus away from that specific market and toward other opportunities it views as having greater potential.
Consumer products and prior acquisitions
CBD of Denver has disclosed that, under the name Berliner Innovation, it has offered consumer products through Libra 9 GmbH. These products include the Magic Lappen and the BerlinR13 Anti-Slip solution, which the company describes as innovative consumer offerings. The company has also discussed its decision to unwind the acquisition of Libra 9 GmbH after concluding that the revenue goals initially presented at the time of the transaction were not met.
Similarly, CBD of Denver moved to unwind its acquisition of Luxora Inc. after determining that regulatory hurdles in Germany limited the potential of that transaction. The company has indicated that preferred shares related to that transaction are to be returned and cancelled as part of the unwinding process.
Expansion into technology and fintech
CBD of Denver has announced a strategic shift toward the broader technology sector. In particular, it has signed a letter of intent with Alchemy Games Co. Ltd, a technology company that specializes in blockchain-based solutions and advanced payment processing. The company describes this move as part of its expansion into financial technology, digital infrastructure and scalable digital solutions.
According to the company’s description, Alchemy Games focuses on high-speed, secure and scalable payment gateways that support both fiat and cryptocurrency transactions. CBD of Denver views this relationship as aligned with its strategy to invest in tech-driven, higher-margin solutions related to digital payments and real-time transaction processing. The company has characterized this collaboration as an important milestone in its expansion into financial technology.
Financial and operational themes
In its public disclosures, CBD of Denver has emphasized several financial and operational themes:
- Improving operating efficiency and reducing operating expenses.
- Returning to positive operating income after prior periods of losses.
- Maintaining what it describes as a cleaner capital structure, including avoiding new convertible debt.
- Focusing on revenue growth while seeking higher-margin opportunities.
The company has also highlighted efforts to strengthen its balance sheet, manage accounts payable, and extend certain notes with supportive debt holders.
Position within the healthcare and tech landscape
While CBD of Denver appears in classifications related to drug manufacturers and healthcare, its own descriptions present it primarily as a holding company with activities spanning cannabis-related infrastructure, wholesale CBD, consumer products and technology-focused ventures. Recent communications place increasing emphasis on digital payments, blockchain, AI and other technology-driven areas, alongside its historical involvement in cannabis-related markets.
Stock Performance
CBD OF DENVER (CBDD) closed at $0.0001 on October 16, 2026. Over the past 12 months, the price has gained 0.0%.
CBDD Metrics & Rankings
Price returns through October 16, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CBD OF DENVER has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. Key topics include acquisition, earnings. View all CBDD news →
SEC Filings
Short Interest History
Short interest in CBD OF DENVER (CBDD) currently stands at 392.8 thousand shares, representing 0.0% of the float. Since October 2025, short interest has increased by 49055.2%.
Days to Cover History
Days to cover for CBD OF DENVER (CBDD) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
CBDD Company Profile & Sector Positioning
CBD OF DENVER (CBDD) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CBDD often look at related companies in the same sector, including SOFTWARE EFF SLTNS CORP (SFWJ), CITY VIEW GREENN HLDGS (CVGRF), WEST ISLAND BRANDS INC (WIBFF), CAN B CORP (CANB), and SIBANNAC INC (SNNC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CBDD's relative position within its industry.